| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012a4af3dc4ad350c812db1b2033023a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b91f81d741def5fb07a38abbbfa56ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9832c7a752d860feaa5ed166f88bf377 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49f0ecc54d6752d0fb3899788637394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757291a1d5edc9985cb1894c8faefd5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d35730690faac0ad5535a374b94752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba6d4a5c0a1c34c2c91b843460854c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b21884cb80b8e596b3ef0f2348b4778c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de5838148ee47b62600963f160cbd9e0 |
| publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2018289864-A1 |
| titleOfInvention |
Coumarin-like cyclic compound as MEK inhibitor and use thereof |
| abstract |
Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof. |
| priorityDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |